Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > what sucks is
View:
Post by spasticated on Nov 07, 2017 1:17pm

what sucks is

when the these lps that have had massive gains start crashing, they'll take EMC down with them.
Comment by gkmackdadzzz1 on Nov 07, 2017 3:17pm
This post has been removed in accordance with Community Policy
Comment by cobills on Nov 07, 2017 4:39pm
What makes you think there will be a short squeeze?
Comment by gkmackdadzzz1 on Nov 07, 2017 5:24pm
This post has been removed in accordance with Community Policy
Comment by SS76 on Nov 08, 2017 11:44am
WEED (Cannibis) will likely retrace to $13-$14 to fill the gap, that will affect CBW and EMC.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities